These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 11900679

  • 1. Advances in imaging for pancreatic disease.
    Del Frate C, Zanardi R, Mortele K, Ros PR.
    Curr Gastroenterol Rep; 2002 Apr; 4(2):140-8. PubMed ID: 11900679
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Computed tomography of pancreatic masses.
    Balthazar EJ, Chako AC.
    Am J Gastroenterol; 1990 Apr; 85(4):343-9. PubMed ID: 2158229
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 6. Efficiency and limitations of angiography in diseases of the pancreas.
    Bücheler E, Boldt I.
    Rofo; 1975 Jul; 123(1):XXVII, XXX. PubMed ID: 176093
    [No Abstract] [Full Text] [Related]

  • 7. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J, Gan G, Farlow D, Laurence JM, Hollands M, Richardson A, Pleass HC, Lam VW.
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and staging of pancreatic cancer by positron emission tomography.
    Berberat P, Friess H, Kashiwagi M, Beger HG, Büchler MW.
    World J Surg; 1999 Sep; 23(9):882-7. PubMed ID: 10449814
    [Abstract] [Full Text] [Related]

  • 9. Computed tomography of the pancreas.
    Freeny PC.
    Clin Gastroenterol; 1984 Sep; 13(3):791-818. PubMed ID: 6091954
    [No Abstract] [Full Text] [Related]

  • 10. Pancreatic imaging: current and emerging technologies.
    Nichols MT, Russ PD, Chen YK.
    Pancreas; 2006 Oct; 33(3):211-20. PubMed ID: 17003640
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic imaging. Computed tomography and magnetic resonance imaging.
    Thoeni RF, Blankenberg F.
    Radiol Clin North Am; 1993 Sep; 31(5):1085-113. PubMed ID: 8395697
    [Abstract] [Full Text] [Related]

  • 12. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.
    Raman SP, Chen Y, Fishman EK.
    Semin Oncol; 2015 Feb; 42(1):40-58. PubMed ID: 25726051
    [Abstract] [Full Text] [Related]

  • 13. The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease.
    Rajput A, Stellato TA, Faulhaber PF, Vesselle HJ, Miraldi F.
    Surgery; 1998 Oct; 124(4):793-7; discussion 797-8. PubMed ID: 9781003
    [Abstract] [Full Text] [Related]

  • 14. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
    Kauhanen S, Rinta-Kiikka I, Kemppainen J, Grönroos J, Kajander S, Seppänen M, Alanen K, Gullichsen R, Nuutila P, Ovaska J.
    J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
    [Abstract] [Full Text] [Related]

  • 16. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH.
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [Abstract] [Full Text] [Related]

  • 17. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
    Sendler A, Avril N, Helmberger H, Stollfuss J, Weber W, Bengel F, Schwaiger M, Roder JD, Siewert JR.
    World J Surg; 2000 Sep; 24(9):1121-9. PubMed ID: 11036292
    [Abstract] [Full Text] [Related]

  • 18. Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US?
    Hanbidge AE.
    Can J Gastroenterol; 2002 Feb; 16(2):101-5. PubMed ID: 11875594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
    Pery C, Meurette G, Ansquer C, Frampas E, Regenet N.
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):465-74. PubMed ID: 20688444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.